Trametinib
Produktgrößen
10 mg
£139,00
10-4759-10MG
10 mM (in 1 ml DMSO)
£149,00
10-4759-10MM(IN1MLDMSO)
50 mg
£195,00
10-4759-50MG
Über dieses Produkt
- SKU:
- 10-4759
- Zusätzliche Namen:
- GSK1120212|JTP-74057
- CAS Number:
- 871700-17-3
- Weitere Details:
- Trametinib is a highly potent (IC50 uMEK1 = 0.7 nM, pp-MEK1 = 14.9 nM)1 and selective MEK inhibitor displaying selective inhibition of proliferation in various BRAF mutant cancer cell lines (IC50 ACHN = 9.8 nM; IC50 HT-29 = 0.57 nM)2. It is approved for use against unresectable or metastatic BRAF-mutant melanoma alone or in combination with Dabrafenib. Trametinib can limit outgrowth of tumors without directly inhibiting tumor cell proliferation via abrogation of cytokine-driven expansion of monocytic myeloid-derived suppressor cells (mMDSC) through a mechanism involving CD8+ T cells.3,4 Trametinib also displays potent anti-arthritic effects.5
- Immunogen:
- Kinase
- Molekulargewicht:
- 615.39
- Physischer Zustand:
- Solid
- Reinheit:
- 98%
- Versandbedingungen:
- Ambient
- Lagerbedingungen:
- -20[o]C
- Hersteller:
- Focus Biomolecules
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Inhibitors
- Sell Sheet 1:
- View Sell Sheet Here